Literature DB >> 2807280

Hepatitis delta virus in homosexual men in Sydney.

N J Bodsworth1, B Donovan, J Gold, Y E Cossart.   

Abstract

In countries not generally endemic for hepatitis B, homosexual men who are carriers of hepatitis B surface antigen (HBsAg) have to date largely been spared additional delta virus infection. A focus of homosexually acquired delta has, however, recently been identified in California. To assess the prevalence and risk factors for delta virus infection in homosexual men in Sydney, we tested the sera of 204 homosexual men with acute or chronic hepatitis B infection for total antibody to delta and delta antigen. Total antibody to delta was detected in eight men and delta antigen in one other (4.4% of the total). All men with antibody or antigen had intravenous drug use as a risk factor. Overall nine of 22 (40.9%) male homosexual intravenous drug users had serological evidence of delta infection. Delta positive patients tended to be younger, to have engaged in prostitution, to have more severe chronic liver disease, to be more likely to have a symptomatic acute illness, and to be less likely to express hepatitis Be antigen (HBeAg) in their sera. Though the homosexual transmission of delta infection cannot be concluded from this study, the detection of delta markers in nine homosexual men (including four prostitutes) suggests considerable potential for dissemination of this virus homosexually.

Entities:  

Mesh:

Year:  1989        PMID: 2807280      PMCID: PMC1194358          DOI: 10.1136/sti.65.4.235

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  18 in total

1.  Human immunodeficiency virus and hepatitis delta virus in homosexual men. A study of four cohorts.

Authors:  R E Solomon; R A Kaslow; J P Phair; D Lyter; B Visscher; D Lyman; M T VanRaden; J Gerin
Journal:  Ann Intern Med       Date:  1988-01       Impact factor: 25.391

2.  e Antigen among male homosexual patients.

Authors:  P D Simmons; M N Islam; S Knott; J E Banatvala; M Supran
Journal:  Br Med J       Date:  1977-12-03

3.  Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.

Authors:  M Rizzetto; R H Purcell; J L Gerin
Journal:  Lancet       Date:  1980-06-07       Impact factor: 79.321

4.  The delta agent.

Authors:  M Rizzetto
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

5.  Nonpercutaneous spread of delta infection.

Authors:  K M De Cock; S Govindarajan; A G Redeker
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

6.  Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

Authors:  M Rizzetto; M G Canese; S Aricò; O Crivelli; C Trepo; F Bonino; G Verme
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

7.  Delta associated hepatitis in Australia.

Authors:  G V Williams; Y E Cossart
Journal:  Aust N Z J Med       Date:  1983-06

8.  Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and hepatitis D virus infections.

Authors:  A G Shattock; F M Irwin; B M Morgan; I B Hillary; M G Kelly; J F Fielding; D A Kelly; D G Weir
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-11

9.  Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment.

Authors:  M Rizzetto; G Verme; S Recchia; F Bonino; P Farci; S Aricò; R Calzia; A Picciotto; M Colombo; H Popper
Journal:  Ann Intern Med       Date:  1983-04       Impact factor: 25.391

10.  Prevalence of hepatitis B "e" antigen and its antibody in various HBsAg carrier populations.

Authors:  W Szmuness; A R Neurath; C E Stevens; N Strick; E J Harley
Journal:  Am J Epidemiol       Date:  1981-02       Impact factor: 4.897

View more
  1 in total

Review 1.  Hepatitis D: Scenario in the Asia-Pacific region.

Authors:  Zaigham Abbas; Wasim Jafri; Sajjad Raza
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.